Scott Barry is a Managing Director at Essex Woodlands Healthcare Partners. See sector focus and contact routes.
Scott Barry is a Managing Director at Essex Woodlands Healthcare Partners, where he leads and serves on the boards of growth equity portfolio companies including Orthovita, Victory Pharma, and Velcera, all of which were later acquired. Prior to joining Essex Woodlands, he was Global Head of Pharma M&A and Collaborations at Novartis Pharma AG, overseeing global acquisitions and equity investments across therapeutic areas. The firm invests exclusively in healthcare, targeting fast-growing, revenue-generating companies with $20M–$200M in annual revenue, primarily in the United States and Europe. Typical investments support portfolio growth through capital, board participation, and strategic guidance, though specific check sizes and lead/follow behavior for Barry are not publicly detailed. Notable portfolio companies under his board involvement include Metabolon, which recently closed a $15 million financing round, and Venus Concept. Barry’s distinctive point of view centers on growth equity in established healthcare businesses rather than early-stage venture, and he has not published public writing on investment philosophy.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Palo Alto.
Investors like Scott Barry · Full investor directory · Investor access · Company funding database